MVP and neoplasm: Twenty out of the 30 patients (66.7%) suffering tumour stages III-IV and negative or fairly positive MVP expression were alive, while 12 out of the 36 patients (33.3%) with tumour stages III-IV and overexpression of MVP were alive.